Transparency Market Research

Global HIV Market to Witness Rapid Growth Due to Patent Trials for HIV Therapeutics Conducted Every Year

Transparency Market Research Report Added "HIV Market" to its database.


Albany, NY -- (SBWIRE) -- 03/16/2016 -- A new market research study by Transparency Market Research provides a detailed analysis of the global HIV market, focusing on the market's overview, including the market's drivers and barriers, geographical segmentation, product portfolio, market trends, and the competitive landscape of the market. The research study, titled "HIV Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020," further presents the historical data and forecast figures of the global HIV market with the help of infographics, charts, tables, and graphs. In addition, valued inputs and recommendations by industry experts are included in the report to guide the market players in designing their company policies effectively.

According to the research study, the global market for HIV therapeutics is driven by the continuous new patent trials that are conducted each year. As a result, the global HIV market remains extremely attractive on the basis of novel drugs and its impact across the globe. Among the major geographical segments, the manufacturers in the Asia Pacific market are facing a tough competitive scenario, coupled with the unique patent laws in several APAC countries, which circumvent the patents of vital life-saving drugs. The prices are further expected to reduce in the APAC market with the participation of several manufacturers, thereby increasing the volume of the overall HIV therapeutics market.

Brochure Download:

On the other hand, the North America market for HIV dominated the global market, accounting for a 50% share in the global market on the basis of overall revenue generated from HIV antivirals. North America is followed by the Europe market, which holds a 30% share in the global HIV market. The rapid growth of these regions can be attributed to the high affordability of HIV drugs, coupled with the array of health insurance options in developed regions. In several emerging markets in South America and Asia Pacific, the major reason of death is the inadequate healthcare standards in the country. In addition, the growing population is another factor adding to the rising concerns about healthcare standards. On the flip side, the current growth trajectory of the Asia Pacific market is an optimistic sign for the major players operating in the global HIV market.

Furthermore, the research report talks about the competitive landscape of the global HIV market, emphasizing on the company profiles, contact information, inception details, financial overview, business policies and strategies, and recent developments, such as any major mergers and acquisitions. Some of the major players operating in the global HIV market are Boehringer Ingelheim, Janssen Therapeutics, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Bristol-Myers Squibb Company, Cipla Limited, Merck & Co. Inc., Abbott Laboratories Inc., and ViiV Healthcare (Pfizer Inc.) and GlaxoSmithKline plc.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453